Literature DB >> 15681793

Selective generation of gut-tropic T cells in gut-associated lymphoid tissues: requirement for GALT dendritic cells and adjuvant.

Marcus Svensson1, Bengt Johansson-Lindbom, Marc-André Wurbel, Bernard Malissen, Gabriel Márquez, William Agace.   

Abstract

To gain entry into peripheral tissues, effector T lymphocytes express specific combinations of adhesion molecules and chemokine receptors. Expression of these are induced during activation in regional secondary lymphoid organs. Herein, we describe a role for GALT DCs in the generation of CCR9(+) alpha(4)beta(7)(+) gut tropic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15681793     DOI: 10.1196/annals.1309.025

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.

Authors:  Yi-Bin Chen; Haesook T Kim; Sean McDonough; Robert D Odze; Xiaopan Yao; Suzan Lazo-Kallanian; Thomas R Spitzer; Robert Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2009-07-08       Impact factor: 5.742

2.  DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells.

Authors:  Morgan A Reuter; Sally Yuan; Preston A Marx; Michele A Kutzler; David B Weiner; Michael R Betts
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

3.  Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant.

Authors:  Noshin Kathuria; Kimberly A Kraynyak; Diane Carnathan; Michael Betts; David B Weiner; Michele A Kutzler
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

Review 4.  Intestinal bacteria and the regulation of immune cell homeostasis.

Authors:  David A Hill; David Artis
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.